Mbx Biosciences, Common Stock Performance
| MBX Stock | 19.83 1.14 5.44% |
On a scale of 0 to 100, MBX Biosciences, holds a performance score of 6. The firm secures a Beta (Market Risk) of 1.31, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, MBX Biosciences, will likely underperform. Please check MBX Biosciences,'s semi variance, as well as the relationship between the daily balance of power and price action indicator , to make a quick decision on whether MBX Biosciences,'s current price movements will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MBX Biosciences, Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, MBX Biosciences, showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 5.75 | Five Day Return 25.19 | Year To Date Return 209.7 M | Ten Year Return 209.7 M | All Time Return 209.7 M |
1 | MARBLEX Price Hits 0.37 on Major Exchanges | 09/17/2024 |
2 | OrbiMed executives purchase 12 million of MBX Biosciences stock | 09/18/2024 |
3 | RTXs Raytheon awarded U.S. Navy contract for Next Generation Jammer Mid-Band Expansion | 10/01/2024 |
4 | MARBLEX Price Tops 0.37 on Top Exchanges | 11/01/2024 |
5 | MARBLEX Price Hits 0.35 on Top Exchanges | 11/06/2024 |
6 | MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update | 11/07/2024 |
7 | MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the ... | 11/18/2024 |
MBX |
MBX Biosciences, Relative Risk vs. Return Landscape
If you would invest 1,600 in MBX Biosciences, Common on August 30, 2024 and sell it today you would earn a total of 383.00 from holding MBX Biosciences, Common or generate 23.94% return on investment over 90 days. MBX Biosciences, Common is generating 0.6625% of daily returns assuming volatility of 8.0541% on return distribution over 90 days investment horizon. In other words, 71% of stocks are less volatile than MBX, and above 87% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
MBX Biosciences, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MBX Biosciences,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MBX Biosciences, Common, and traders can use it to determine the average amount a MBX Biosciences,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0823
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MBX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.05 actual daily | 71 71% of assets are less volatile |
Expected Return
| 0.66 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average MBX Biosciences, is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MBX Biosciences, by adding it to a well-diversified portfolio.
MBX Biosciences, Fundamentals Growth
MBX Stock prices reflect investors' perceptions of the future prospects and financial health of MBX Biosciences,, and MBX Biosciences, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MBX Stock performance.
| Current Valuation | 613.91 M | ||||
| Shares Outstanding | 31.85 M | ||||
| EBITDA | (50.72 M) | ||||
| Total Debt | 156.65 M | ||||
| Book Value Per Share | (6.18) X | ||||
| Earnings Per Share | (1.48) X | ||||
| Total Asset | 84.18 M | ||||
| Retained Earnings | (75.58 M) | ||||
About MBX Biosciences, Performance
Evaluating MBX Biosciences,'s performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if MBX Biosciences, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MBX Biosciences, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
MBX Biosciences, is entity of United States. It is traded as Stock on NASDAQ exchange.Things to note about MBX Biosciences, Common performance evaluation
Checking the ongoing alerts about MBX Biosciences, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MBX Biosciences, Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MBX Biosciences, is way too risky over 90 days horizon | |
| MBX Biosciences, appears to be risky and price may revert if volatility continues | |
| Latest headline from gurufocus.com: MBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the ... |
- Analyzing MBX Biosciences,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MBX Biosciences,'s stock is overvalued or undervalued compared to its peers.
- Examining MBX Biosciences,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MBX Biosciences,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of MBX Biosciences,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MBX Biosciences,'s stock. These opinions can provide insight into MBX Biosciences,'s potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MBX Stock Analysis
When running MBX Biosciences,'s price analysis, check to measure MBX Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences, is operating at the current time. Most of MBX Biosciences,'s value examination focuses on studying past and present price action to predict the probability of MBX Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences,'s price. Additionally, you may evaluate how the addition of MBX Biosciences, to your portfolios can decrease your overall portfolio volatility.